DSIP vs NAD+ Precursors
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Delta Sleep Inducing Peptide, Delta Sleep-Inducing Peptide
DSIP, or delta sleep-inducing peptide, is a small naturally occurring nonapeptide (sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in the 1970s from the blood of sleeping rabbits. As the name suggests, it was named for its ability to promote delta-wave (deep, slow-wave) sleep in animals. Despite five decades of study it has no regulatory approval and the human evidence for it as a sleep aid is weak and inconsistent.
Also: NMN, NR
NAD+ precursors are not peptides. They are small molecules, mainly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), that the body converts into NAD+, a coenzyme every cell needs to make energy and run repair enzymes. NAD+ falls with age, so these precursors are sold as anti-aging and metabolic supplements. Human trials confirm they reliably raise blood NAD+ levels, but clear proof of real health benefits in people is still missing.
Key Comparison Insights
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
Detailed Comparison
| Attribute | DSIP | NAD+ Precursors |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | How DSIP actually works is still not nailed down, which is unusual for a peptide this old. It does not have one clear receptor of its own. Instead it seems to act as a modulator, influencing slow-wave sleep, neurotransmitter levels, circadian rhythm, hormone release (including growth hormone), and stress responses. One striking animal finding: injecting antibodies against DSIP into the brain blocked the normal rise in slow-wave sleep and growth hormone, hinting that the body's own DSIP plays a real regulatory role. Some reports also suggest it can act on opioid-related pathways, which is why it has been studied in addiction withdrawal. Treat these mechanisms as plausible but not fully proven. | NAD+ is a workhorse coenzyme for cellular energy metabolism and for enzymes like sirtuins and PARPs that handle DNA repair and stress response. The body builds NAD+ along the salvage pathway: the enzyme NAMPT turns nicotinamide into NMN, and NMNAT enzymes then convert NMN into NAD+. NR enters this route one step upstream, getting phosphorylated into NMN before becoming NAD+. The logic of supplementing is simple: feed the pathway more raw material and you raise the NAD+ pool that declines with age. One wrinkle from recent human work is that gut bacteria may convert some NR and NMN into nicotinic acid before it ever reaches tissues, so the real-world route to higher NAD+ is messier than the textbook diagram. |
| Common Dosing | 100-250 mcg before bed Once daily, 30 min before sleep | Limited community data available See research protocols |
| Administration | Subcutaneous, intramuscular, or intranasal | Oral (capsules, sublingual) |
| Typical Duration | 2-4 weeks typical | Ongoing supplementation |
| Best Time to Take | 30-60 minutes before bed | Morning or before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The early animal work was genuinely interesting: DSIP reliably increased delta sleep in rabbits, rats, and mice, and seemed tied to growth hormone release during sleep. The human data is far less convincing. A few small studies reported longer or better sleep after intravenous DSIP in chronic insomniacs, with no daytime grogginess. But a double-blind, placebo-controlled study published in Neuropsychobiology (1992) concluded that short-term DSIP treatment of chronic insomnia is unlikely to be of major therapeutic benefit, since objective gains were weak and patients did not feel their sleep was better. Separate older reports claimed high success rates relieving opiate and alcohol withdrawal symptoms, but these were small, uncontrolled, and never replicated to modern standards. Bottom line: real history, real animal data, but no solid randomized evidence that it works as a sleep drug in people. | The one thing human trials agree on is that these precursors work as NAD+ boosters: randomized placebo-controlled studies show chronic NR is well tolerated and raises NAD+ in healthy middle-aged and older adults, and head-to-head work found NR and NMN both roughly doubled circulating NAD+ over about two weeks, while plain nicotinamide did not. The harder question is whether that biochemical bump translates into anything you would feel. A meta-analysis of NAD+ precursor effects on glucose and lipid metabolism found inconclusive, modest, and inconsistent results, and outcomes vary a lot between people depending on age, health, genetics, and gut microbiome. So the accurate framing is: yes, they raise NAD+ and appear safe short term, but robust evidence that they slow aging, improve metabolic disease, or extend healthspan in humans does not yet exist. Most of the dramatic claims come from mouse studies, not people. |
Frequently Asked Questions: DSIP vs NAD+ Precursors
What is the difference between DSIP and NAD+ Precursors?
DSIP is a anti-aging peptide that dsip, or delta sleep-inducing peptide, is a small naturally occurring nonapeptide (sequence trp-ala-gly-gly-asp-ala-ser-gly-glu) first isolated in the 1970s from the blood of sleeping rabbits. as the name suggests, it was named for its ability to promote delta-wave (deep, slow-wave) sleep in animals. despite five decades of study it has no regulatory approval and the human evidence for it as a sleep aid is weak and inconsistent. NAD+ Precursors is a anti-aging peptide that nad+ precursors are not peptides. they are small molecules, mainly nicotinamide riboside (nr) and nicotinamide mononucleotide (nmn), that the body converts into nad+, a coenzyme every cell needs to make energy and run repair enzymes. nad+ falls with age, so these precursors are sold as anti-aging and metabolic supplements. human trials confirm they reliably raise blood nad+ levels, but clear proof of real health benefits in people is still missing. The main differences lie in their mechanisms of action and clinical applications.
Which is better, DSIP or NAD+ Precursors?
Neither is universally "better" - the choice depends on your specific goals. DSIP is typically used for anti-aging purposes, while NAD+ Precursors is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can DSIP and NAD+ Precursors be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using DSIP and NAD+ Precursors together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.